AZTA - NASDAQ

Azenta, Inc.

AZTA·NASDAQ

$23.89

+2.0%

HealthcareMedical - Instruments & Supplies

Azenta, Inc. provides life science sample exploration and management solutions for the life sciences market in North America, Europe, China, the Asia Pacific, and internationally. The company operates through two reportable segments, Life Sciences Products and Life Sciences Services. The Life Sciences Products segment offers automated cold sample management systems for compound and biological sample storage; equipment for sample preparation and handling; consumables; and instruments that help customers in managing samples throughout their research discovery and development workflows. The Life Sciences Services segment provides comprehensive sample management programs, integrated cold chain solutions, informatics, and sample-based laboratory services to advance scientific research and support drug development. This segment's services include sample storage, genomic sequencing, gene synthesis, laboratory processing, laboratory analysis, biospecimen procurement, and other support services. It serves a range of life science customers, including pharmaceutical companies, biotechnology companies, biorepositories, and research institutes. The company was formerly known as Brooks Automation, Inc. and changed its name to Azenta, Inc. in December 2021. Azenta, Inc. was founded in 1978 and is headquartered in Chelmsford, Massachusetts.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$1.10B

EPS-1.2200

P/E Ratio-19.58

Earnings Date08/04/2026

2.06B

Assets

-2%

3Y-45.0%

5Y+32.0%

10Y+200.0%

330.70M

Total Liabilities

3Y-6.0%

5Y-4.0%

10Y+150.0%

1.73B

Total Equity

-2%

3Y-49.0%

5Y+42.0%

10Y+212.0%

Azenta, Inc. Funding & Solvency Profile

AZTA · NASDAQ

Current Assets

Cash & Cash Equivalents279.78M

Net Receivables189.21M

Inventory74.96M

Other Current Assets103.25M

Total Current Assets708 M

Non-Current Assets

Property, Plant & Equipment208.00M

Goodwill & Intangible Assets804.21M

Long-Term Investments247.19M

Other Non-Current Assets91.12M

Total Non-Current Assets546 M

Total Assets

2.06B

Financial Health Analysis

Current Ratio

2.98x

Excellent liquidity position. The company can easily cover its short-term obligations with substantial cushion.

Debt-to-Equity Ratio

0.19x

Conservative capital structure. The company relies primarily on equity financing, indicating low financial risk.

Working Capital

471 M

Strong working capital position provides significant operational flexibility and financial cushion.

Asset Composition

34% Current

Capital-intensive business with significant long-term investments in property, equipment, or intangibles.

Financial Health Insight

Strong financial foundation: Excellent liquidity combined with conservative leverage suggests the company is well-positioned to weather economic uncertainties and fund growth opportunities.

Azenta, Inc. Balance Sheet

AZTA • NASDAQ

Azenta, Inc. Balance Sheet	Sep 2025	Sep 2024	Sep 2023	Sep 2022	Sep 2021	Sep 2020	Sep 2019	Sep 2018	Sep 2017	Sep 2016	Sep 2015	Sep 2014	Sep 2013	Sep 2012	Sep 2011	Sep 2010	Sep 2009	Sep 2008	Sep 2007	Sep 2006
ASSETS
CURRENT ASSETS
Cash and Cash Equivalents	279.8M	310.9M	678.9M	658.3M	227.4M	295.6M	301.6M	197.7M	101.6M	85.1M	80.7M	94.1M	83M	54.6M	58.8M	59.8M	60M	110.3M	168.2M	115.8M
Short-Term Investments	61.1M	151.2M	338.9M	911.8M	81K	67K	34.1M	46.3M	28K	39K	70M	68.1M	45.9M	85.6M	65.7M	49M	28M	33.1M	80.1M	68.3M
Cash & Short-Term Investments	340.9M	462.1M	1B	1.6B	227.5M	295.7M	335.8M	244M	101.7M	85.1M	150.7M	162.2M	128.9M	140.3M	124.5M	108.8M	88M	143.3M	248.3M	184.1M
Net Receivables	189.2M	172.7M	156.5M	163.8M	119.9M	94.8M	165.6M	125.2M	93.5M	106.4M	86.4M	80.1M	77.5M	78.9M	76.7M	92.3M	38.4M	75.6M	105.9M	113.4M
Accounts Receivables	179.5M	172.7M	156.5M	163.8M	119.9M	94.8M	165.6M	125.2M	93.5M	106.4M	86.4M	80.1M	77.5M	78.9M	76.7M	92.3M	38.4M	66.8M	105.9M	113.4M
Other Receivables	9.7M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.8M	0.0	0.0
Inventory	75M	115.3M	128.2M	85.5M	60.4M	114.8M	99.4M	97M	106.4M	92.6M	100.6M	93.6M	97.7M	103M	107.7M	115.8M	84.7M	105.9M	104.8M	99.9M
Prepaids	0.0	0.0	0.0	132.6M	51.1M	44M	46.3M	31.7M	22.6M	15.3M	15.2M	19.4M	9M	9.1M	10.3M	10.4M	10M	13.8M	20.5M	21.7M
Other Current Assets	103.3M	82.7M	116.4M	507.4M	318.5M	222.9M	0.0	97.9M	60.7M	15.3M	35.7M	38.4M	44.8M	16.3M	1.3M	0.0	0.0	0.0	20.5M	13.8M
Total Current Assets	708.3M	832.8M	1.4B	2.5B	777.4M	649.5M	648.2M	564.8M	352M	299.3M	373.5M	374.3M	330.1M	347.5M	320.5M	327.3M	221.2M	338.6M	479.5M	432.8M
NON-CURRENT ASSETS
Property, Plant, and Equipment (Net)	208M	266.6M	205.7M	154.5M	130.7M	117.7M	100.7M	60M	58.5M	54.9M	41.9M	50.2M	47.9M	64.5M	68.6M	63.7M	74.8M	81.6M	80.7M	78.8M
Goodwill	702.4M	691.4M	784.3M	513.6M	469.4M	501.5M	488.6M	255.9M	233.6M	202.1M	121.4M	109.5M	122M	88.4M	84.7M	48.1M	48.1M	120M	319.3M	351.4M
Intangible Assets	101.8M	248M	294.3M	178.4M	186.5M	218.3M	251.2M	100M	83.5M	81.8M	55.4M	59.6M	60.1M	39.4M	44.3M	11.1M	14.1M	58.5M	77M	94.1M
Goodwill & Intangible Assets	804.2M	939.4M	1.1B	692M	655.9M	719.9M	739.8M	355.8M	317.2M	284M	176.9M	169.1M	182.1M	127.8M	129M	59.3M	62.2M	178.4M	396.3M	445.5M
Long-Term Investments	247.2M	49.5M	111.3M	352M	3.6M	3.1M	2.8M	7.2M	31.2M	33.4M	87.6M	112.2M	70.2M	91.4M	115.9M	65.3M	52M	33.9M	26.3M	7.3M
Tax Assets	726K	837K	571K	1.2M	10M	5M	5.1M	43.8M	1.7M	2M	70.5M	67.6M	99.1M	104.6M	0.0	0.0	0.0	-33.9M	-26.3M	-7.3M
Other Non-Current Assets	91.1M	10.9M	70.5M	57.1M	241.9M	64.1M	20.5M	64.3M	6.1M	12.4M	9.4M	4.8M	7.3M	6.2M	2.6M	2.6M	3.2M	65M	58.3M	35.4M
Total Non-Current Assets	1.4B	1.3B	1.5B	1.3B	1B	909.7M	868.9M	531.2M	414.6M	386.6M	386.2M	403.7M	406.6M	394.5M	316.1M	190.9M	192.1M	325M	535.3M	559.8M
Total Assets	2.1B	2.1B	2.9B	3.7B	1.8B	1.6B	1.5B	1.1B	766.6M	685.9M	759.7M	778M	736.8M	742M	636.6M	518.2M	413.3M	663.6M	1B	992.6M
LIABILITIES
CURRENT LIABILITIES
Total Payables	47.1M	57.8M	43.2M	67.1M	51.1M	27.7M	158.2M	62.6M	60.5M	48.7M	52.3M	36.4M	36.5M	30.7M	44.2M	66.8M	29M	40.4M	73.9M	69.3M
Accounts Payable	37.7M	44.4M	35.8M	38.7M	42.4M	25.7M	58.9M	44.7M	49.1M	41.1M	44.9M	33.7M	35.4M	29M	40.2M	65.7M	26.4M	37.2M	57.8M	69.3M
Other Payables	9.4M	13.4M	7.4M	28.4M	8.7M	2M	99.3M	17.9M	11.4M	7.6M	7.4M	2.6M	1.1M	1.7M	4M	1M	2.7M	6.3M	32.2M	0.0
Accrued Expenses	35.8M	0.0	33.9M	41.9M	106.2M	45.4M	31.4M	29.3M	23.9M	21.3M	20.4M	21.7M	14.2M	14.1M	37.5M	37M	38.5M	62.1M	23.9M	81.4M
Short Term Debt	7.8M	0.0	0.0	0.0	0.0	827K	829K	2M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11K
Capital Lease Obligations (Current)	0.0	10.5M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	881K	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Tax Payables	9.7M	13.3M	7.4M	28.4M	8.7M	10.1M	99.4M	6.7M	11.4M	7.6M	6.1M	1.8M	1.1M	1.7M	4M	1M	2.7M	3.2M	16.1M	17.8M
Deferred Revenue	32.6M	32M	34.6M	39.7M	25.7M	31.4M	29.5M	26.6M	24.3M	15M	17.9M	26.3M	19.7M	10M	14.1M	4.4M	2.9M	3.6M	5.4M	26.1M
Other Current Liabilities	114.4M	104.5M	99.2M	81.8M	162.1M	111.5M	52.4M	44.8M	39.8M	34.9M	23.7M	28.7M	22.3M	26.4M	0.0	0.0	0.0	-3.2M	39.7M	21.2M
Total Current Liabilities	237.7M	204.8M	210.9M	230.5M	345.1M	211.1M	273M	165.4M	146.8M	119.8M	114.3M	113.8M	92.6M	81.2M	95.7M	108.2M	70.5M	102.9M	142.8M	180.2M
NON-CURRENT LIABILITIES
Long Term Debt	51.2M	0.0	0.0	0.0	49.7M	49.6M	50.3M	194.1M	0.0	0.0	0.0	7.4M	0.0	0.0	0.0	0.0	10.8M	0.0	0.0	2K
Deferred Revenue (Non-Current)	0.0	0.0	0.0	0.0	0.0	6.4M	5.3M	5M	0.0	0.0	0.0	1.8M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Deferred Tax Liabilities (Non-Current)	18.2M	54.2M	0.0	66.2M	15M	37M	38.9M	8.2M	5.4M	5.6M	6.8M	8.3M	99.1M	104.6M	0.0	0.0	0.0	0.0	0.0	0.0
Other Non-Current Liabilities	-28.6M	11.9M	79.9M	6.7M	39.3M	48.2M	33.8M	11.6M	8.5M	9.5M	6.5M	6.5M	4.5M	11.5M	22.3M	20.7M	12.5M	18.4M	11.8M	12.9M
Total Non-Current Liabilities	93M	126.2M	140.3M	122.2M	149.1M	134.4M	104.8M	212.8M	12.2M	12.4M	13.4M	21.3M	11.5M	11.5M	22.3M	20.7M	23.2M	18.4M	11.8M	12.9M
Capital Lease Obligations	52.1M	70.7M	60.4M	49.2M	45.1M	31.9M	2.7M	0.0	0.0	0.0	0.0	8.3M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Total Liabilities	330.7M	331.1M	351.2M	352.7M	494.2M	345.5M	377.8M	378.2M	159M	132.2M	127.6M	135.1M	104.1M	92.7M	118M	128.9M	93.7M	121.2M	154.6M	193M
SHAREHOLDERS' EQUITY
Treasury Stock	-201M	-201M	-201M	-201M	-201M	-201M	-201M	-201M	-201M	-201M	-201M	-201M	-201M	-201M	-201M	-201M	-201M	-201M	-110.8M	0.0
Common Stock	594K	590K	713K	885K	878K	873K	857K	841K	833K	821K	811K	804K	800K	798K	797K	789K	779K	770K	765K	754K
Additional Paid-In Capital	529.6M	506M	1.2B	2B	2B	1.9B	1.9B	1.9B	1.9B	1.9B	1.8B	1.8B	1.8B	1.8B	1.8B	1.8B	1.8B	1.8B	1.8B	1.8B
Retained Earnings	1.4B	1.5B	1.6B	1.7B	-470.1M	-551.1M	-586.1M	-994.1M	-1.1B	-1.1B	-1B	-1B	-1B	-992.5M	-1.1B	-1.2B	-1.3B	-1.1B	-828.8M	-980.3M
Accumulated Other Comprehensive Income/Loss	-22.2M	-13.5M	-62.4M	-83.9M	19.4M	21.9M	3.5M	13.6M	15.2M	15.2M	5.9M	15.7M	22.6M	23.6M	19.5M	19.5M	16.3M	18.1M	18.2M	15.4M
Total Stockholders' Equity	1.7B	1.8B	2.5B	3.4B	1.3B	1.2B	1.1B	717.8M	607.6M	553.7M	632M	642.9M	632M	648.7M	518M	388.8M	319.1M	542M	859.8M	799.1M
Total Equity	1.7B	1.8B	2.5B	3.4B	1.3B	1.2B	1.1B	717.8M	607.6M	553.7M	632M	642.9M	632.7M	649.3M	518.6M	389.4M	319.6M	542.4M	860.2M	799.5M
Minority Interest	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	700K	635K	589K	537K	494K	409K	463K	394K
SUMMARY
Total Liabilities & Equity	2.1B	2.1B	2.9B	3.7B	1.8B	1.6B	1.5B	1.1B	766.6M	685.9M	759.7M	778M	736.8M	742M	636.6M	518.2M	413.3M	663.6M	1B	992.6M
Total Investments	308.3M	200.6M	450.2M	1.3B	3.7M	3.2M	37M	53.5M	31.3M	33.4M	157.6M	180.3M	116.1M	177M	181.6M	114.4M	80M	67M	106.4M	75.6M
Total Debt	111.2M	70.7M	60.4M	49.2M	94.8M	82.3M	51.1M	196.1M	0.0	0.0	0.0	8.3M	0.0	0.0	0.0	0.0	10.8M	0.0	0.0	13K
Net Debt	-168.6M	-240.3M	-618.5M	-609M	-132.7M	-213.4M	-250.5M	-1.6M	-101.6M	-85.1M	-80.7M	-85.8M	-83M	-54.6M	-58.8M	-59.8M	-49.2M	-110.3M	-168.2M	-115.8M
Shares Outstanding	45,839,728	45,839,728	45,839,728	45,839,728	45,839,728	45,839,728	45,839,728	45,839,728	45,839,728	45,839,728	45,839,728	45,839,728	45,839,728	45,839,728	45,839,728	45,839,728	45,839,728	45,839,728	45,839,728	45,839,728

SEC Filings

AZTA - Filing history and reports

Filing Type	Filing Date	Period Ending	Fiscal Year	Actions
10-Q 10-Q 2026 Q1 Q1	May 08, 2026	March 31, 2026	2026	View Filing
8-K 8-K 2026 N/A	May 05, 2026	May 05, 2026	2026	View Filing
8-K 8-K 2026 N/A	April 07, 2026	April 06, 2026	2026	View Filing
8-K 8-K 2026 N/A	April 02, 2026	March 27, 2026	2026	View Filing
8-K 8-K 2026 N/A	March 04, 2026	March 04, 2026	2026	View Filing
10-Q 10-Q 2025 Q4 Q4	February 05, 2026	December 31, 2025	2025	View Filing
8-K 8-K 2026 N/A	February 04, 2026	February 04, 2026	2026	View Filing
8-K 8-K 2026 N/A	February 02, 2026	January 29, 2026	2026	View Filing
8-K 8-K 2026 N/A	January 29, 2026	January 28, 2026	2026	View Filing
8-K 8-K 2025 N/A	December 29, 2025	December 23, 2025	2025	View Filing

Showing 1 to 10 of 477 filings

Related Guides

Blog Categories

Continue your AZTA research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.